Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Reich

Showing results (131-140 of 138) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 138 results.
Nephron|June 20, 2015
A Multicenter Randomized Controlled Trial of Rituximab versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (MENTOR)Fernando C Fervenza, Pietro A Canetta, Sean J Barbour, et al.
The New England Journal of Medicine|July 4, 2019
Rituximab or Cyclosporine in the Treatment of Membranous NephropathyFernando C Fervenza, Gerald B Appel, Sean J Barbour, et al.
Kidney International|January 18, 2013
Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approachCrystal A Gadegbeku, Debbie S Gipson, Lawrence B Holzman, et al.
Clinical Kidney Journal|September 9, 2020
The longitudinal relationship between patient-reported outcomes and clinical characteristics among patients with focal segmental glomerulosclerosis in the Nephrotic Syndrome Study NetworkJonathan P Troost, Anne Waldo, Noelle E Carlozzi, et al.
Pediatric Nephrology (Berlin, Germany)|March 1, 2021
APOL1 genotype-associated morphologic changes among patients with focal segmental glomerulosclerosisJarcy Zee, Michelle T McNulty, Jeffrey B Hodgin, et al.
Kidney International Reports|November 20, 2018
Clinical Characteristics and Treatment Patterns of Children and Adults With IgA Nephropathy or IgA Vasculitis: Findings From the CureGN StudyDavid T Selewski, Josephine M Ambruzs, Gerald B Appel, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 15, 2015
Complete Remission in the Nephrotic Syndrome Study NetworkDebbie S Gipson, Jonathan P Troost, Richard A Lafayette, et al.
Kidney International|November 28, 2022
Precision nephrology identified tumor necrosis factor activation variability in minimal change disease and focal segmental glomerulosclerosisLaura H Mariani, Sean Eddy, Fadhl M AlAkwaa, et al.
Pageof 14

Showing results (131-140 of 138) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 138 results.
Nephron|June 20, 2015
A Multicenter Randomized Controlled Trial of Rituximab versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (MENTOR)Fernando C Fervenza, Pietro A Canetta, Sean J Barbour, et al.
The New England Journal of Medicine|July 4, 2019
Rituximab or Cyclosporine in the Treatment of Membranous NephropathyFernando C Fervenza, Gerald B Appel, Sean J Barbour, et al.
Kidney International|January 18, 2013
Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approachCrystal A Gadegbeku, Debbie S Gipson, Lawrence B Holzman, et al.
Clinical Kidney Journal|September 9, 2020
The longitudinal relationship between patient-reported outcomes and clinical characteristics among patients with focal segmental glomerulosclerosis in the Nephrotic Syndrome Study NetworkJonathan P Troost, Anne Waldo, Noelle E Carlozzi, et al.
Pediatric Nephrology (Berlin, Germany)|March 1, 2021
APOL1 genotype-associated morphologic changes among patients with focal segmental glomerulosclerosisJarcy Zee, Michelle T McNulty, Jeffrey B Hodgin, et al.
Kidney International Reports|November 20, 2018
Clinical Characteristics and Treatment Patterns of Children and Adults With IgA Nephropathy or IgA Vasculitis: Findings From the CureGN StudyDavid T Selewski, Josephine M Ambruzs, Gerald B Appel, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 15, 2015
Complete Remission in the Nephrotic Syndrome Study NetworkDebbie S Gipson, Jonathan P Troost, Richard A Lafayette, et al.
Kidney International|November 28, 2022
Precision nephrology identified tumor necrosis factor activation variability in minimal change disease and focal segmental glomerulosclerosisLaura H Mariani, Sean Eddy, Fadhl M AlAkwaa, et al.
Pageof 14